NCT Number: NCT00391885
Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy
This study compares the manual administration of propofol and remifentanil and their delivery using a combined closed-loop anesthesia system, entropy of the EEG being the controller.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Dept of Anesthesia and Intensive Care, Hôpital Beaujon, Clichy, France
About this study
Several monitors are currently proposed to evaluate the depth of hypnosis. Among them, Bispectral Index (BIS) is a well known and widely used parameter derived from the patient's electroencephalograph (EEG). A closed-loop anesthesia system can be built using BIS as the control variable, a proportional-integral-differential control algorithm, a propofol and a remifentanil target-controlled infusion systems as the control actuators Preliminary results show that this system can be used during surgery.
Spectral entropy relies on the extent of disorder in both EEG and electromyography (EMG) signals and returns 2 values: State Entropy (SE) and Response Entropy. SE is computed over the frequency range of 0.8-32 Hz and reflects the level of hypnosis while Response Entropy is computed over the frequency range of 0.8-47 Hz and reflects also EMG activity. BIS and SE are dimensionless numbers scaled from 100 to 0 for BIS and from 91 to 0 for SE. We hypothesized that SE can be used as the control variable. In preparation for a large multi-center control trial, we propose a prospective randomized study to evaluate the effectiveness of such a closed-loop anesthesia system. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups, the goal is to maintain SE between 40 and 60, the recommended range during anesthesia by the manufacturer. We expect the combined closed-loop anesthesia system group to do similar or better.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- American Society of Anesthesiologists physical status 1-3,
- surgery under general anesthesia using relaxant agent,
- surgery lasting more than one hour
Exclusion criteria
- pregnant women,
- indication for rapid sequence induction,
- anticipation of difficult intubation,
- allergy to propofol or remifentanil,
- neurological or muscular disorder,
- combination of general anesthesia and of regional anesthesia,
- emergency surgery
Treatment and study plan
Primary outcomes
-
Global score (calculated parameter which depicts the performance of the system, i.e. its capacity to maintain BIS in the desired range)
Secondary outcomes
-
consumption of propofol and remifentanil during the induction and the maintenance of the anaesthesia
-
number of modifications of target of propofol and remifentanil
-
number of episodes of hemodynamic anomalies having required a treatment
-
intraoperative volume loading and transfusion
-
extubation time, explicit memorisation
-
dysfunctions of each system
Sponsors and collaborators
Lead sponsor
Hopital Foch
Other
Registry information
Official study title
Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy of the Electroencephalogram: Comparison Between Manual Perfusion and Automated Perfusion
Important dates
- Study start
- 2006
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Oct 25, 2006
- Registry last updated
- Sep 27, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex
NCT06220136
Anesthesia, General, Neuromuscular Blockade
Ankara, Altındağ, Turkey (Türkiye)
View Trial DetailsComparison of Acoustic Variability Index (AVI) and Pulse Pressure Variation (PPV) for Predicting Fluid Responsiveness in Mechanically Ventilated Patients
NCT07516470
Anesthesia, General, Fluid Responsiveness Predictability
Seoul, South Korea
View Trial DetailsLMA Protector vs I-Gel in Low-Flow Anesthesia for Laparoscopic Cholecystectomy
NCT07707440
Anesthesia, General, Laparoscopic Cholecystectomy
Istanbul, Turkey (Türkiye)
View Trial DetailsInduction Agents in ECT: Effects on Seizure Duration, Quality, and Recovery
NCT07596095
Anesthesia, General, Electroconvulsive Therapy
Istanbul, Turkey (Türkiye)
View Trial Details